Fireside Ventures leads funding round of Rs 50 crore in Amaha
Mumbai: Amaha has announced securing a substantial investment of over INR 50 crore as an extended series A round. This round of funding was led by Fireside Ventures investing INR 36.4 crore as well as additional investment of INR 15+ crore by other strategic investors.
"Over time, Amaha has successfully raised one of the largest investments in mental health in India," the Company stated.
The Amaha mental health ecosystem provides treatment and care for a range of mental health conditions like anxiety, depression, bipolar disorder, ADHD, OCD, schizophrenia, and addictions. The organisation was founded by psychiatrist and healthcare entrepreneur Dr Amit Malik and joined by social entrepreneur Neha Kirpal as co-founder, to address the mental health treatment gap prevalent in India.
Dr. Amit Malik, Founder and CEO of Amaha, expressing his eagerness about the recent funding, stated, “The INR 50+ Crore infusion helps consolidate Amaha’s position as the leading mental healthcare provider in India and accelerates the company’s strategic expansion plans, as it continues to address the dynamic mental health challenges faced by individuals, families and organisations across the country. The partnership with Fireside Ventures creates exciting possibilities for cross-sectoral collaborations, propelling Amaha’s efforts to mainstream mental health access to all those in need.”
Ankur Khaitan, Principal, Fireside Ventures said, “At Fireside, our outlook is to look for companies building for well-being and in that context, the space of addressing mental health issues is a large unmet need in India. Amaha with their deep clinical expertise and unique business model across digital and offline clinics will be able to solve for awareness and access to a wider audience.”
Amaha acquired & partnered with India’s foremost Child and Adolescent mental health organisation Children First two years ago.
Read also: Strides Pharma shares sold by 2 entities for Rs 81 crore
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.